Paws & Tails™
Product details
Vvaan Vaquon Tablets are a prescription-strength veterinary medication formulated by Vvaan Life Sciences, containing Atovaquone USP 250 mg, a potent antiprotozoal and antimicrobial agent. This medication is widely used in the treatment and prevention of serious protozoal infections and respiratory disorders in dogs and cats, and is also indicated for use in horses under veterinary supervision.
Atovaquone plays a critical role in managing tick-borne and parasitic diseases, making Vaquon Tablets a trusted choice among veterinarians for complex and life-threatening infections.
Atovaquone USP 250 mg
Excipients: q.s.
Powerful Antiprotozoal Action: Effective against a range of protozoal infections.
Respiratory Support: Used in the prevention and treatment of pneumonia and other lung disorders.
Broad Veterinary Application: Suitable for dogs, cats, and horses (as prescribed).
Veterinarian-Trusted Formulation: Manufactured by Vvaan Life Sciences with strict quality standards.
Vvaan Vaquon Tablets are commonly prescribed for:
Babesia gibsoni infection (tick fever) in dogs
Pneumocystis pneumonia
Other protozoal infections
Cytauxzoonosis in cats
Cytauxzoon felis (C. felis) infections
For certain conditions, especially Babesiosis and Cytauxzoonosis, Vaquon Tablets are often administered in combination with Azithromycin, as advised by a veterinarian.
Usual Dosage: 13.3 mg/kg body weight every 8 hours for 10 days
Route: Oral administration
Usage: Veterinary use only
Use only under veterinary prescription and supervision
Not intended for human use
Monitor pets for any adverse reactions during treatment
10 tablets per strip
Similar products